Susquehanna International Group, LLP Sc Pharmaceuticals Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 73,909 shares of SCPH stock, worth $288,984. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,909
Previous 21,266
247.55%
Holding current value
$288,984
Previous $75,000
158.67%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding SCPH
# of Institutions
91Shares Held
36.3MCall Options Held
121KPut Options Held
2K-
Orbimed Advisors LLC San Diego, CA6.06MShares$23.7 Million0.5% of portfolio
-
Rubric Capital Management LP New York, NY4.78MShares$18.7 Million0.36% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4.1MShares$16 Million5.81% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX3.12MShares$12.2 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$7.79 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $107M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...